Evidence map›Paper›PMID 34069549›Full record

ArticleAntioxidants (Basel, Switzerland)2021

The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial.

Mahmoud M A Abulmeaty, Ghadeer S Aljuraiban, Sumaya M Shaikh, Naif E ALEid, Lulwa R Al Mazrou, Abdullah A Turjoman, Mona S Aldosari, Suhail Razak, Mervat M El-Sayed, Tahani M Areabi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Mahmoud M A AbulmeatyDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11362, Saudi Arabia.ORCID 0000-0002-1779-0091
Ghadeer S AljuraibanDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11362, Saudi Arabia.ORCID 0000-0002-4866-5461
Sumaya M ShaikhPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Naif E ALEidPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Lulwa R Al MazrouPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Abdullah A TurjomanPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Mona S AldosariClinical Nutrition Department, King Saud University Medical City, Riyadh 11472, Saudi Arabia.
Suhail RazakDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11362, Saudi Arabia.
Mervat M El-SayedCollege of Food Sciences and Agriculture, King Saud University, Riyadh 11362, Saudi Arabia.
Tahani M AreabiPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Rokia M AlsalafiPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Yasser S Al-HelioPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Abdulrhman B AlmutairyPrince Mohamed Bin Abdulaziz Hospital, Riyadh 14214, Saudi Arabia.
Haneen N MollaClinical Nutrition Department, King Saud University Medical City, Riyadh 11472, Saudi Arabia.
Prince Mohammed bin Abdulaziz Hospital · SAKing Saud University · SAKing Saud Medical City · SA

Funding

the Ministry of Health, Kingdom of Saudi Arabia. grant number #558
6 · The paper itself

Abstract

Modulation of cytokine production using immunonutrition is a relatively novel concept to improve outcomes among patients with SARS-CoV-2 infection and is now hypothesized to help manage COVID-19, however, clinical evidence is lacking. This prospective, double-blinded, randomized parallel-controlled interventional clinical trial investigated the effect of antioxidant supplements on inflammatory cytokines and disease progression in non-critically ill patients. A total of 87 hospitalized COVID-19 patients were randomized using computer-generated-randomization into the supplement group (

Indexed as

antioxidantsCOVID-19cytokine stormnon-critically ill

Identifiers

PMID34069549
PMCPMC8160844
OpenAlexW3161191210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.